NCT00334581View on ClinicalTrials.gov

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

PHASE4CompletedINTERVENTIONAL

Enrollment

192

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Hypertension

Interventions

DRUG

Irbesartan

Administration throughout the study period

DRUG

Irbesartan

Administration throughout the study period

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Shanghai

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY